HomeComparePHMMF vs PM

PHMMF vs PM: Dividend Comparison 2026

PHMMF yields 0.97% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PHMMF wins by $88.9K in total portfolio value· pulled ahead in Year 8
10 years
PHMMF
PHMMF
● Live price
0.97%
Share price
$96.00
Annual div
$0.93
5Y div CAGR
68.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$138.5K
Annual income
$65,086.57
Full PHMMF calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — PHMMF vs PM

📍 PHMMF pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPHMMFPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PHMMF + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PHMMF pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHMMF
Annual income on $10K today (after 15% tax)
$82.26/yr
After 10yr DRIP, annual income (after tax)
$55,323.58/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, PHMMF beats the other by $53,205.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHMMF + PM for your $10,000?

PHMMF: 50%PM: 50%
100% PM50/50100% PHMMF
Portfolio after 10yr
$94.0K
Annual income
$33,789.29/yr
Blended yield
35.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

PHMMF
No analyst data
Altman Z
8.3
Piotroski
6/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHMMF buys
0
PM buys
0
No recent congressional trades found for PHMMF or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPHMMFPM
Forward yield0.97%3.48%
Annual dividend / share$0.93$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR68.1%17.2%
Portfolio after 10y$138.5K$49.6K
Annual income after 10y$65,086.57$2,492.02
Total dividends collected$111.9K$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PHMMF vs PM ($10,000, DRIP)

YearPHMMF PortfolioPHMMF Income/yrPM PortfolioPM Income/yrGap
1$10,863$162.67$11,648$408.29$785.00PM
2$11,901$277.61$13,589$495.90$1.7KPM
3$13,212$477.81$15,877$603.21$2.7KPM
4$14,970$833.33$18,580$734.88$3.6KPM
5$17,501$1,483.41$21,781$896.75$4.3KPM
6$21,451$2,724.54$25,578$1,096.12$4.1KPM
7$28,198$5,246.31$30,092$1,342.17$1.9KPM
8← crossover$41,007$10,834.88$35,470$1,646.46+$5.5KPHMMF
9$68,632$24,753.88$41,892$2,023.58+$26.7KPHMMF
10$138,522$65,086.57$49,578$2,492.02+$88.9KPHMMF

PHMMF vs PM: Complete Analysis 2026

PHMMFStock

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.

Full PHMMF Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this PHMMF vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHMMF vs SCHDPHMMF vs JEPIPHMMF vs OPHMMF vs KOPHMMF vs MAINPHMMF vs MOPHMMF vs BTIPHMMF vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.